Wide complex tachycardias

Revision as of 22:42, 18 January 2009 by Zorkun (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for Wide complex tachycardias

Articles

Most recent articles on Wide complex tachycardias

Most cited articles on Wide complex tachycardias

Review articles on Wide complex tachycardias

Articles on Wide complex tachycardias in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Wide complex tachycardias

Images of Wide complex tachycardias

Photos of Wide complex tachycardias

Podcasts & MP3s on Wide complex tachycardias

Videos on Wide complex tachycardias

Evidence Based Medicine

Cochrane Collaboration on Wide complex tachycardias

Bandolier on Wide complex tachycardias

TRIP on Wide complex tachycardias

Clinical Trials

Ongoing Trials on Wide complex tachycardias at Clinical Trials.gov

Trial results on Wide complex tachycardias

Clinical Trials on Wide complex tachycardias at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Wide complex tachycardias

NICE Guidance on Wide complex tachycardias

NHS PRODIGY Guidance

FDA on Wide complex tachycardias

CDC on Wide complex tachycardias

Books

Books on Wide complex tachycardias

News

Wide complex tachycardias in the news

Be alerted to news on Wide complex tachycardias

News trends on Wide complex tachycardias

Commentary

Blogs on Wide complex tachycardias

Definitions

Definitions of Wide complex tachycardias

Patient Resources / Community

Patient resources on Wide complex tachycardias

Discussion groups on Wide complex tachycardias

Patient Handouts on Wide complex tachycardias

Directions to Hospitals Treating Wide complex tachycardias

Risk calculators and risk factors for Wide complex tachycardias

Healthcare Provider Resources

Symptoms of Wide complex tachycardias

Causes & Risk Factors for Wide complex tachycardias

Diagnostic studies for Wide complex tachycardias

Treatment of Wide complex tachycardias

Continuing Medical Education (CME)

CME Programs on Wide complex tachycardias

International

Wide complex tachycardias en Espanol

Wide complex tachycardias en Francais

Business

Wide complex tachycardias in the Marketplace

Patents on Wide complex tachycardias

Experimental / Informatics

List of terms related to Wide complex tachycardias

Cardiology Network

Discuss Wide complex tachycardias further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Wide complex tachycardia or WCT refers to a cardiac rhythm of more than 100 bpm with a QRS duration of 120 ms or more on the surface electrocardiogram.

Definition

Heart rate >100 with QRS duration >120ms.

Background

  • Wide complex tachycardia (WCT) can be either:
    1. Supra ventricular tachycardia (SVT) with aberrancy
    2. Ventricular tachycardia (VT)
    3. Antegrade conduction down an accessory bypass tract.
  • 80% of WCT will be VT. 98% will be VT if structural heart disease is present. 7% of patients with SVT will have prior myocardial infarction (MI).

Differential Diagnosis

  • Regular
    • VT (slight irregularity of RR)
    • SVT with aberrancy: Sinus, atrial tachycardia (AT), or Flutter.
    • Antidromic atrioventricular reentrant tachycardia (AVRT)
  • Irregular
  • The mechanism of SVT with aberrancy is usually concealed retrograde conduction. The ventricular beat penetrates the right branch (RB) or left branch (LB). When the next supraventricular activation front occurs that bundle is refractory and if conduction can occur, it will proceed down the other bundle. Since the RB has a longer refractory period than the LB, a right bundle branch block (RBBB) morphology is more common.
  • Other mechanisms of “rate related aberrancy” are preexisting bundle branch block (BBB), physiologic (phase 3) aberration and use dependent aberration secondary to medication. In physiologic aberration, the stimulus comes to the His-Purkinje system before it has fully recovered from the previous stimulus. The ensuing activation is either blocked or conducts slowly. Again, the RB is the one more at risk. Most commonly seen at the onset of paroxysmal supraventricular tachycardia (PSVT), but can become sustained.
  • In use-dependent aberration, a patient on and anti-arrhythmic (especially Ic agents) will have a progressive decrement in ventricular conduction rate the more it is stimulated. During faster heart rates, less time is available for the drug to dissociate from the receptor and an increased number of receptors are blocked.

Differentiation of VT from Antidromic AVRT

  • Angina pectoris (AP) activate ventricles from base to apex by virtue of their location in the atrioventricular (AV) ring. This results in predominately positive QRS complexes in V4-V6. If negative, favors VT. For same reason, qR complexes in V2-V4 cannot be found in AVRT unless there is preexisting heart disease.[1] [2] [3]
  • Because the atria are part of the circuit in AVRT, any relationship other than 1:1 of P and QRS means VT (100%).

Algorithm

  1. If polarity of V4-V6 is negative, then VT (100%).
  2. If qR present in V4-V6, then VT (100%).
  3. If 1:1 AV relationship not present (more QRS than P), then VT. (100%)
  • If none of above present, 25% will still be VT

History and Symptoms

  • Age
  • Presence of preexisting heart disease
  • Duration of symptoms
  • Medications

Physical Examination

  • Vitals to assess hemodynamic stability
  • “Cannon-a waves” (a manifestation of AV dissociation)
  • Carotid sinus massage (CSM)/Valsalva: ST can gradually slow. MAT, AT, Flutter, and AF may transiently slow. An AV nodal dependent WCT may terminate. AV dissociation may become more apparent with CSM in VT. VT can terminate with CSM

Electrocardiogram

  • Extreme axis deviation favors VT. Especially -90 to -180 or “northwest” or “superior” axis. (23% of SVT will have SAD)
  • QRS duration >140 msec favors VT (21% of VT will have QRS <140 msec)
  • AV dissociation is demonstrated in only 21% of VT
  • Morphologic Criteria
    • 4% of SVT and 6% of VT did not fulfill criteria in any lead
    • 40% will have discordance between V1/V2 and V5/V6. One lead may suggest VT while another suggests SVT.
  • An algorithmic approach was proposed by Brugada in 1991. It has a reported sensitivity of 99% and specificity of 97%.

Pharmacotherapy

Acute Pharmacotherapies

  • If stable: (More patients than you think)
  • DO NOT USE Ca2+ Channel blocker, Digoxin or Adenosine if you don't not know the etiology of the Wide Complex Tachycardia. Ca2+ Channel blockers and Digoxin can lead to accelerated conduction down a bypass tract and VF.
  • Though ACLS guidelines recommend a diagnostic trial of Adenosine, it can precipitate VF in some patients with SVT. Patients who have underlying coronary disease may become ischemic from coronary steal. Rhythm can degenerate and lead to VF that cannot be resuscitated. Furthermore, some VT (esp those with structurally normal hearts) are adenosine responsive and can terminate.
    1. Etiology Uncertain
      • Pronestyl 15mg/kg load over 30 minutes then 2-6mg/min gtt
    2. Ventricular Tachycardia with active ischemia
      • Lidocaine 1 mg/kg q5-10 min up to 3 times then 2-6mg.min gtt
      • If unsuccessful, Pronestyl as above
      • If unsuccessful, IV Amiodarone 150-300 load over 15-20min. 30-60mg/hr gtt for total of 1gram
    3. Ventricular Tachycardia in Setting of Cardiomyopathy
    4. Positively SVT with aberrancy
    5. Antidromic AVRT
      • If 100% positive AF is not underlying, can terminate with a nodal blocker
      • If unsure, Pronestyl as above
  • Pearls from MEJ

Surgery and Device Based Therapy

  • Hypotension with symptoms, chest pain, congestive heart failure (CHF), seizure etc.: Defibrillate

References

  1. Brugada P, Brugada J, Mont L et al. A new approach to the differential diagnosis of a regular tachycardia with wide QRS complex. Circulation. 1991;83: 1649-1659. PMID 2022022
  2. Kindwall KE, Brown, J, Josephson ME. Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiology. 1988; 61:1279-1283. PMID 3376886
  3. Podrid P, Brugada P. Approach to wide QRS complex tachycardias. Up To Date. 1998.


Template:SIB


Template:WikiDoc Sources Template:Mdr